Certificate of Analysis
Purity
≥98.0%
Method
HPLC / MS
Testing
Third-Party
COA Status
Available
Cagrilintide
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Select Size / Specification
Selected: 5mg x 10 vials
Choose Pack Size
Quantity
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Pricing & Specifications
| Specification | Strength | Pack | Total Qty | 1 Vial | 3 Vial Bundle | 10 Vial Kit | Kit Savings |
|---|---|---|---|---|---|---|---|
| 5mg x 10 vials | 5 MG | 10 | 50 MG | $65.00 | $185.25 | $487.5025% off | $162.50 |
| 10mg x 10vials | 10 MG | 10 | 100 MG | $115.00 | $327.75 | $862.5025% off | $287.50 |
About Cagrilintide
Cagrilintide (AM833) is a long-acting synthetic analog of human amylin — a 37-amino acid pancreatic peptide hormone co-secreted with insulin from beta cells. The compound incorporates multiple α-aminoisobutyric acid (Aib) substitutions for protease resistance and a C18 fatty acid modification that promotes albumin binding and extended preclinical half-life compared to native amylin. Amylin itself activates calcitonin receptor-like receptors (CLRs) in combination with receptor activity-modifying proteins (RAMPs), and cagrilintide is designed to maintain this receptor pharmacology with improved stability characteristics.
In research settings, cagrilintide has been studied for its interaction with amylin receptor subtypes AMY1–AMY3 in cell-based binding assays, downstream signaling pathway characterization, and comparative pharmacological profiling relative to pramlintide and native amylin. The compound is of scientific interest as a single agent and in combination with GLP-1 receptor agonists in controlled laboratory investigations examining the coordination of incretin and amylinergic receptor signaling.
Peptide / Compound Information
| Property | Value |
|---|---|
| Peptide Sequence | Amylin analog: 37-AA modified sequence with C18 fatty acid modification and multiple Aib substitutions |
| Molecular Formula | C167H268N50O55S3 |
| Molecular Weight | 3,907.4 g/mol |
| CAS Number | 2190688-95-6 |
| Synonyms | AM833, Long-acting amylin analog |
Lyophilized Research Peptides
This product is supplied in lyophilized (freeze-dried) form — a process that extends shelf life and preserves peptide purity and structural integrity during storage. No fillers, excipients, or preservatives are used in the lyophilization process. The lyophilized powder should be reconstituted with an appropriate research-grade solvent in a controlled laboratory environment prior to use in in vitro or preclinical assay systems.
99%+
PURITY
Third Party Tested
Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.
GMP
CERT.
GMP Manufacturing Standards
Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.
FAST
SHIP
Best in Class Fulfillment
Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.
ZERO
FILLERS
Zero Fillers or Additives
Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.
Scientific Content Review
All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.
Cagrilintide is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
5MG, 10MG
COA
Available